MHLW’s COVID-19 Guide Recommends against Camostat after Trial Failures

July 7, 2021
The Ministry of Health, Labor and Welfare (MHLW) updated its COVID-19 care guide on July 5, recommending against the use of the protease enzyme inhibitor camostat mesilate (brand name: Foipan) to treat the disease after it failed to show efficacy...read more